More than 30 years ago a clinical trial to evaluate the efficacy of IFNα in inhibiting VZV infection in children suffering from cancer indicated that IFN treatment could limit the dissemination of severe varicella lesions (93). This evidence concerns the gene IFNA1 and chickenpox.